ABOUT Dr. Gupta
Shruti was born in Delhi, India and grew up in Falls Church, Virginia. Shruti enjoys spending time with her husband, Erik, and her daughter, Nayla, with another on the way!
Medical Training
Shruti earned her undergraduate degree from Yale University and then attended medical school at the University of Virginia, where she was inducted into the Alpha Omega Alpha society. She completed her internal medicine residency at Massachusetts General Hospital, where she was a chief resident at Newton Wellesley Hospital, and then did her nephrology training at Brigham and Women’s Hospital and Massachusetts General Hospital. During her fellowship, Shruti was mentored by Dr. Gary Curhan and Dr. David Leaf, and she obtained a Masters in Public Health at the Harvard School of Public Health.
Areas of Interest
Shruti is now Director of Onconephrology at Brigham and Women’s Hospital and Dana-Farber Cancer Institute. She conducts epidemiologic, translational, and interventional studies related to the nephrotoxic effects of cancer therapies. Some of Shruti’s current areas of investigation include novel biomarkers and therapeutic targets for cisplatin-associated acute kidney injury, immune checkpoint inhibitor-associated acute kidney injury, methotrexate-associated acute kidney injury, and myeloma light chain cast nephropathy.
Accomplishements
In 2021, Shruti founded the American Society of Onconephrology and was co-president until December of 2022. She is an Assistant Professor of Medicine at Harvard Medical School and is currently funded by an NIH K23 award, as well as some industry grants. She serves on the Mass General Brigham Institutional Review Board. Her publications have appeared in leading medical journals including Annals of Internal Medicine and JAMA Internal Medicine. Her research has been featured in The New York Times, Washington Post, and CNN.